tiprankstipranks
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Financial Statements

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Financial Overview

BrightPath Biotherapeutics Co.Ltd.'s market cap is currently ¥3.84B. The company's EPS TTM is ¥-13.505; its P/E ratio is ―; BrightPath Biotherapeutics Co.Ltd. is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M¥ 11.30M
Gross Profit¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M¥ 6.83M
Operating Income¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B¥ -1.83B
EBITDA¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B¥ -1.76B
Net Income¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B¥ -1.86B
Balance Sheet
Cash & Short-Term Investments¥ 1.06B¥ 1.53B¥ 2.31B¥ 3.27B¥ 3.02B
Total Assets¥ 1.23B¥ 1.70B¥ 2.77B¥ 3.75B¥ 3.47B
Total Debt¥ 112.50M¥ 0.00¥ 87.50M¥ 0.00¥ 0.00
Net Debt¥ -944.86M¥ -1.53B¥ -2.22B¥ -3.27B¥ -3.02B
Total Liabilities¥ 251.27M¥ 133.91M¥ 239.73M¥ 211.79M¥ 239.40M
Stockholders' Equity¥ 978.99M¥ 1.57B¥ 2.53B¥ 3.54B¥ 3.24B
Cash Flow
Free Cash Flow¥ -1.16B¥ -1.21B¥ -1.53B¥ -1.81B¥ -1.89B
Operating Cash Flow¥ -1.16B¥ -1.20B¥ -1.51B¥ -1.77B¥ -1.78B
Investing Cash Flow¥ -7.65M¥ -1.76M¥ -17.57M¥ -36.21M¥ -106.88M
Financing Cash Flow¥ 690.96M¥ 432.10M¥ 569.23M¥ 2.05B¥ 8.52M
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History

BrightPath Biotherapeutics Co.Ltd. Debt to Assets

BrightPath Biotherapeutics Co.Ltd. Cash Flow

BrightPath Biotherapeutics Co.Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis